Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases-Reference-Cited by-同舟云学术

Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases

Published:2019-02-02 Issue:1 Volume:175 Page:51-57
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Liu Zhi-Hua,Wang Kun,Lin Dan-Yi,Xu Jie,Chen Jie,Long Xiao-Yu,Ge Yan,Luo Xin-Lan,Zhang Ke-Ping,Liu Yan-Hui,Xu Fang-Ping

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-019-05148-5/fulltext.html

Reference37 articles.

1. McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321:624–628

2. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF, American Society of Clinical Oncology/College of American P (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131:18–43. https://doi.org/10.1043/1543-2165(2007)131%5B18:ASOCCO%5D2.0.CO;2

3. Adamczyk A, Kruczak A, Harazin-Lechowska A, Ambicka A, Grela-Wojewoda A, Domagala-Haduch M, Janecka-Widla A, Majchrzyk K, Cichocka A, Rys J, Niemiec J (2018) Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment. Onco Targets Ther 11:4525–4535. https://doi.org/10.2147/OTT.S166983

4. Cooke T, Reeves J, Lannigan A, Stanton P (2001) The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker. Eur J Cancer 37(Suppl 1):S3–S10

5. Curigliano G, Viale G, Bagnardi V, Fumagalli L, Locatelli M, Rotmensz N, Ghisini R, Colleoni M, Munzone E, Veronesi P, Zurrida S, Nole F, Goldhirsch A (2009) Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer. J Clin Oncol 27:5693–5699. https://doi.org/10.1200/JCO.2009.22.0962

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2GAN: Overcome the Scarcity of HER2 Breast Cancer Dataset Based on Transfer Learning and GAN Model;CLIN BREAST CANCER;2024

2. HER2GAN: Overcome the Scarcity of HER2 Breast Cancer Dataset Based on Transfer Learning and GAN Model;Clinical Breast Cancer;2024-01

3. Weakly supervised bilayer convolutional network in segmentation of HER2 related cells to guide HER2 targeted therapies;Computerized Medical Imaging and Graphics;2023-09

4. Comparative Analysis of Clinical and Molecular Characteristics in Invasive Ductal Carcinoma of the Breast;2023-08-02

5. Detection of ERBB2 and CEN17 signals in fluorescent in situ hybridization and dual in situ hybridization for guiding breast cancer HER2 target therapy;Artificial Intelligence in Medicine;2023-07